Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Chitte who wrote (2776)	7/22/1999 7:33:00 PM
From: vibaby	Read Replies (2) \| Respond to of 4140

Prob. open down at least $5-$8... Great buying opp. because they WILL eventually get approval if their cash holds out.

To: Jacques Chitte who wrote (2776)	7/22/1999 7:44:00 PM
From: Jay	Read Replies (1) \| Respond to of 4140

I think I've mentioned this before, but look at last year's chart of ATIS to get an idea. They basically had the same thing happen to them, i.e. go back and do more testing. They were trading around 15 and dropped to 2. I imagine it will all depend on what exactly they need to do and how much time they need to get it done. They may have to partner with another company, if that is possible. All the best to all the longs on this thread. This is heartbreaking. As usual, it shows the risk is very real for companies waiting for FDA approval. Good luck all, Jay